Hyperfine (HYPR) EBIT Margin Growth (1y) (2022 - 2026)
Hyperfine (HYPR) EBIT Margin Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | -497.00 |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 670.00 |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 301.00 |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 546.00 |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 264.00 |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 595.00 |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 89.00 |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | -247.00 |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 146.00 |
| 10 | Hyperfine | 90.47 Mn | 45.70 Mn | 1.98 Mn | 13,897.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13,897.00 |
| Mar 31, 2026 | 29,089.00 |
| Dec 31, 2025 | 31,894.00 |
| Sep 30, 2025 | 4,140.00 |
| Jun 30, 2025 | -5,719.00 |
| Mar 31, 2025 | -18,694.00 |
| Dec 31, 2024 | -3,086.00 |
| Sep 30, 2024 | 20,374.00 |
| Jun 30, 2024 | 4,711.00 |
| Mar 31, 2024 | 17,147.00 |
| Dec 31, 2023 | 52,414.00 |
| Sep 30, 2023 | 6,099.00 |
| Jun 30, 2023 | 116,704.00 |
| Mar 31, 2023 | 108,059.00 |
| Dec 31, 2022 | 502,616.00 |
| Sep 30, 2022 | 385,212.00 |
| Jun 30, 2022 | 256,145.00 |
| Mar 31, 2022 | 78,272.00 |